Abstract Regulatory T cells (Tregs) are essential for maintaining immune homeostasis and preventing autoimmune diseases, but are also a major cellular constituent of the tumor microenvironment (TME) that facilitates cancer progression. Identifying differences in Treg subtypes to specifically disrupt the activities of tumor-promoting Tregs, without affecting Tregs that maintain immune homeostasis remain a challenge.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Brian Riesenberg
The chromatin-organizer Satb1 modulates regulatory T cell activity within the tumor microenvironment
Intra-tumoral hypoxia promotes CD8+ T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4
|
By Brian Riesenberg, Evelyn Gandy, Andrew Kennedy, Genevieve Clutton, Jessica W. Hem, Katie Hurst, Elizabeth G. Hunt, Brian Miller, Steven P Angus, Gary Johnson, Robert J. Esther, Jennifer L. Guerriero, Peng Gao, David R. Soto-Pantoja, Robert Ferris Verified, Jennifer L Modliszewski, Michael Coleman, H. Kay Chung, J. Justin Milner, Stergios J Moschos, R. Luke Wiseman, Jessica E. Thaxton
|
Cell Press
Verified
Keywords T cell immunotherapy tumor microenvironment hypoxia integrated stress response ATF4 mitochondria metabolism Introduction Cancer poses a significant challenge to global public health and is the second leading cause of mortality in the United States.1 Conventional cancer treatments include surgery, chemotherapy, and radiation therapy; however, these treatments are hampered by drug resistance, severe toxicities, and limited efficacy.2 The development of immune checkpoint inhibitor (ICI)...
276 Endoplasmic reticulum composition dictates antitumor function in CAR T cells
http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.
Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment
Highlights • The tumor microenvironment induces lipid droplet (LD) accumulation in dysfunctional CD8+ TILs • Acetyl-CoA carboxylase (ACC) directs LD accumulation in CD8+ T cells • Inhibition of ACC in CD8+ T cells facilitates fatty acid oxidation • Restraining ACC promotes CD8+ TIL persistence and tumor control Summary The solid tumor microenvironment (TME) imprints a compromised metabolic state in tumor-infiltrating T cells (TILs), hallmarked by the inability to maintain effective energy...
Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment
Highlights • The tumor microenvironment induces lipid droplet (LD) accumulation in dysfunctional CD8+ TILs • Acetyl-CoA carboxylase (ACC) directs LD accumulation in CD8+ T cells • Inhibition of ACC in CD8+ T cells facilitates fatty acid oxidation • Restraining ACC promotes CD8+ TIL persistence and tumor control Summary The solid tumor microenvironment (TME) imprints a compromised metabolic state in tumor-infiltrating T cells (TILs), hallmarked by the inability to maintain effective energy...
Acetyl-CoA Carboxylase Obstructs CD8+ T-Cell Lipid Utilization and Energy Synthesis in the Tumor Microenvironment
Abstract The solid tumor microenvironment (TME) imprints a compromised metabolic state in tumor infiltrating T cells (TILs) hallmarked by the inability to maintain effective energy synthesis for antitumor function and survival. T cells in the TME must catabolize lipids via mitochondrial fatty acid oxidation (FAO) to supply energy in nutrient stress, and it is established that T cells enriched in FAO are adept at cancer control.
Adaptive IRE1 Signaling Elicits T Cell Metabolic Remodeling and Tumor Control
Abstract The efficacy of cancer immunotherapies is limited by the metabolic instability of the tumor microenvironment (TME) that disables T cell antitumor immunity. Metabolic imbalances within the TME are sensed and responded to by stress sensors of the endoplasmic reticulum (ER) unfolded protein response (UPR). The UPR comprises three integrated signaling pathways harboring both adaptive and deleterious phases based on the extent and duration of cell stress.
RNA binding protein PCBP1 is an intracellular immune checkpoint for shaping T cell responses in cancer immunity
Abstract Distinct lineages of T cells can act in response to various environmental cues to either drive or restrict immune-mediated pathology. Here, we identify the RNA binding protein, poly(C)-binding protein 1 (PCBP1) as an intracellular immune checkpoint that is up-regulated in activated T cells to prevent conversion of effector T (Teff) cells into regulatory T (Treg) cells, by restricting the expression of Teff cell–intrinsic Treg commitment programs.
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β
Download and print this article for your personal scholarly, research, and educational use. Buy a single issue of Science for just $15 USD.
Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade
Brian P. Riesenberg, Ephraim A. Ansa-Addo, Jennifer Gutierrez, Cynthia D. Timmers, Bei Liu and Zihai Li J Immunol September 1, 2019, 203 (5) 1105-1110; DOI: https://doi.org/10.4049/jimmunol.1900594 Key Points Platelets alter frequency, phenotype, and function of tumor-infiltrating lymphocytes. Inhibition of platelet activation improves CD8+ T cell–dependent tumor control. Pretreatment with antiplatelet therapy enhances responsiveness to PD-1 blockade.
Cutting Edge: Targeting Thrombocytes to Rewire Anticancer Immunity in the Tumor Microenvironment and Potentiate Efficacy of PD-1 Blockade
Brian P. Riesenberg, Ephraim A. Ansa-Addo, Jennifer Gutierrez, Cynthia D. Timmers, Bei Liu and Zihai Li J Immunol July 29, 2019, ji1900594; DOI: https://doi.org/10.4049/jimmunol.1900594 Key Points Platelets alter frequency, phenotype, and function of tumor-infiltrating lymphocytes. Inhibition of platelet activation improves CD8+ T cell–dependent tumor control. Pretreatment with antiplatelet therapy enhances responsiveness to PD-1 blockade.
Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells
Translational Science Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells C. Bryce Johnson, Bennett R. May, Brian P. Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John M. Wrangle, David J. Cole and Mark P. Rubinstein
Enhanced lymphodepletion is insufficient to replace exogenous IL-2 or IL-15 therapy in augmenting the efficacy of adoptively transferred effector CD8+ T cells
Enhanced lymphodepletion is insufficient to replace exogenous IL-2 or IL-15 therapy in augmenting the efficacy of adoptively transferred effector CD8+ T cells C. Bryce Johnson, Bennett R May, Brian P Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garret-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John Wrangle, David J Cole and Mark P. Rubinstein Cancer Res April 10 2018 DOI: 10.1158/0008-5472.CAN-17-2153
Platelets subvert T cell immunity against cancer via GARP-TGFβ axis
Cancer, like microbes, can adapt to a single therapy, making combination therapies the approach of choice. Complementary therapies that decrease immunosuppression may boost the efficacy of immunotherapies. Now, Rachidi et al. report that targeting platelets improves adoptive T cell therapy of multiple cancers in mice. They found that transforming growth factor ?
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Brian
Contact Brian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack